As global markets navigate a complex landscape marked by interest rate adjustments and sector-specific shifts, the U.S. indices have shown resilience with notable performances in mid-cap and small-cap segments. Amidst these developments, identifying growth stocks with high insider ownership can be particularly appealing, as such companies often demonstrate strong alignment between management and shareholder interests, potentially enhancing their capacity for sustained growth in fluctuating market conditions.
Name | Insider Ownership | Earnings Growth |
Lavvi Empreendimentos Imobiliários (BOVESPA:LAVV3) | 11.9% | 21.1% |
Atlas Energy Solutions (NYSE:AESI) | 29.1% | 41.9% |
Archean Chemical Industries (NSEI:ACI) | 22.9% | 34% |
Kirloskar Pneumatic (BSE:505283) | 30.3% | 30.1% |
Clinuvel Pharmaceuticals (ASX:CUV) | 10.4% | 27.4% |
Laopu Gold (SEHK:6181) | 36.4% | 33.2% |
Medley (TSE:4480) | 34% | 30.4% |
KebNi (OM:KEBNI B) | 36.3% | 86.1% |
EHang Holdings (NasdaqGM:EH) | 32.8% | 81.4% |
Credo Technology Group Holding (NasdaqGS:CRDO) | 13.9% | 95% |
Let's review some notable picks from our screened stocks.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Pharma Mar, S.A. is a biopharmaceutical company focused on the research, development, production, and commercialization of bio-active principles for oncology across various international markets, with a market cap of €1.21 billion.
Operations: The company generates revenue primarily from its oncology segment, amounting to €194.09 million.
Insider Ownership: 11.8%
Earnings Growth Forecast: 55.1% p.a.
PharmaMar is poised for growth with its earnings expected to increase by 55.11% annually, outpacing the broader Spanish market. Despite a recent dip in net income to €3.54 million, positive clinical trial results for Zepzelca® could bolster future revenue streams. The company's forecasted high return on equity of 36.2% in three years and substantial insider ownership underline confidence in its long-term potential, though share price volatility remains a concern.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Will Semiconductor Co., Ltd. is a semiconductor design company offering sensor, analog, and touch screen and display solutions with a market cap of CN¥136.09 billion.
Operations: The company's revenue is generated from its sensor solutions, analog solutions, and touch screen and display solutions.
Insider Ownership: 30.7%
Earnings Growth Forecast: 38.9% p.a.
Will Semiconductor's recent earnings report highlights substantial growth, with net income rising to CNY 1.37 billion from CNY 153.12 million a year ago. Revenue also increased significantly, reaching CNY 12.09 billion for H1 2024. The company's earnings are forecasted to grow at an impressive rate of nearly 39% annually, outpacing the Chinese market average of about 24%. Despite no significant insider trading activity recently, high insider ownership suggests confidence in its growth trajectory.
Simply Wall St Growth Rating: ★★★★★☆
Overview: International Games System Co., Ltd. engages in the planning, design, research, development, manufacturing, marketing, servicing, and licensing of arcade, online, and mobile games primarily in Taiwan, the United Kingdom, and China with a market cap of NT$312.80 billion.
Operations: The company's revenue is primarily generated from its Online Games Division, contributing NT$8.99 billion, and its Business Game Division, which accounts for NT$7.13 billion.
Insider Ownership: 12.5%
Earnings Growth Forecast: 21.5% p.a.
International Games System Ltd. has demonstrated strong financial performance, with Q2 2024 sales reaching TWD 4.58 billion and net income rising to TWD 2.28 billion from the previous year. Its earnings are forecasted to grow significantly at over 21% annually, surpassing the Taiwan market average of approximately 19%. Recently added to the FTSE All-World Index, this inclusion reflects its growing prominence despite a highly volatile share price in recent months.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com